Ignite Creation Date:
2025-12-24 @ 7:07 PM
Ignite Modification Date:
2026-02-25 @ 4:58 PM
Study NCT ID:
NCT02586857
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-29
First Post:
2015-10-17
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 1b/2, Multicenter, Open-label Study of ACP-196 in Subjects With Recurrent Glioblastoma Multiforme (GBM)
Sponsor:
Acerta Pharma BV
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-01-25
Start Date Type:
ACTUAL
Primary Completion Date:
2020-06-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-04-01
Completion Date Type:
ESTIMATED
First Submit Date:
2015-10-17
First Submit QC Date:
None
Study First Post Date:
2015-10-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-04-30
Results First Submit QC Date:
None
Results First Post Date:
2020-07-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-25
Last Update Post Date:
2025-09-29
Last Update Post Date Type:
ESTIMATED